AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9653638
Drug: Coping-oriented group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coping-oriented group therapy
Trial: 12588464
Drug: Sumatriptan (SUM)
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sumatriptan (SUM) 6 mg s.c. injected in the morning and afternoon
Trial: 12589283
Drug: Weekly Gel
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly Gel (Karigel‐N for 4 minutes weekly)
Trial: 18791483
Drug: Herbal combination
RxNorm normalized name: HERBAL MISCELLANEOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal combination therapy (Hypericum perforatum and Vitex agnus-castus)
Trial: 14581124
Drug: Oral delta-9-THC
RxNorm normalized name: delta-9-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral delta-9-THC 5 mg
Trial: 31025878
Drug: Insulin patch
RxNorm normalized name: CeQur Simplicity 4-Day Insulin Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin patch
Trial: 25099185
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate (1000 mg, once daily) and prednisolone (5 mg, twice daily)
Trial: 19442491
Drug: Tapering off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering off current antipsychotic over 4 weeks with aripiprazole (10 mg)
Trial: 19442491
Drug: Tapering off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering off current antipsychotic over 6 weeks with aripiprazole (10 mg)
Trial: 22838970
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme (ACE) inhibitors
Trial: 7923485
Drug: Incontinent patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incontinent patients with rectal prolapse
Trial: 10702450
Drug: Epidural droperidol
RxNorm normalized name: Droperidol
DrugBank: Droperidol (DB00450)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural droperidol 1.25 mg
Trial: 10702450
Drug: Epidural droperidol
RxNorm normalized name: Droperidol
DrugBank: Droperidol (DB00450)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural droperidol 2.5 mg
Trial: 10702450
Drug: Epidural droperidol
RxNorm normalized name: Droperidol
DrugBank: Droperidol (DB00450)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural droperidol 5.0 mg
Trial: 28644348
Drug: Lactulose mannitol
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose mannitol ratio (L:M) test
Trial: 28381246
Drug: FIT programme
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FIT programme (daily group handwashing with soap, toothbrushing with fluoride toothpaste, biannual school-based deworming, construction of handwashing facilities)
Trial: 7793298
Drug: Insulin sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin sensitivity in obese FH subgroup
Trial: 19890274
Drug: Epoetin-alfa treatment
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin-alfa treatment with high hemoglobin target (13.5 g/l)
Trial: 10629708
Drug: Organ sparing
RxNorm normalized name: argan oil
DrugBank: Argan oil (DB14310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organ sparing treatment (sectorial resection +/‐ axillary dissection)
Trial: 7861019
Drug: Prior zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prior zidovudine therapy
Trial: 956103
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ascorbic acid
Trial: 25277061
Drug: Flurbiprofen lozenges
RxNorm normalized name: flurbiprofen Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen lozenges (new generic formulation by Epifarma Srl)
Trial: 20023215
Drug: Concurrent rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Concurrent rituximab (375 mg/m2) plus infusional EPOCH chemotherapy
Trial: 10629434
Drug: d-fenfluramine (D-FEN)
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-fenfluramine (D-FEN) 15 mg
Trial: 10629434
Drug: ipsapirone (IPS)
RxNorm normalized name: IP-2018
DrugBank: IP-2018 (DB19049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ipsapirone (IPS) 10 mg
Trial: 2735338
Drug: Sucralfate suspension
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate suspension
Trial: 8997012
Drug: Antacid suspension
RxNorm normalized name: Antacid Suspension
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid suspension
Trial: 28734822
Drug: Icotinib 125
RxNorm normalized name: niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icotinib 125 mg orally (three times per day)
Trial: 29855972
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (IGlar)
Trial: 25803346
Drug: Balloon-expandable stent
RxNorm normalized name: castor fiber scent gland secretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon-expandable stent plus medical therapy (stent group; n=59)
Trial: 21734600
Drug: Saccharomyces boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saccharomyces boulardii (200 mg, twice per day for 5 days)
Trial: 22871888
Drug: β-blocker
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blocker
Trial: 11880017
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg
Trial: 9543445
Drug: gp160 in
RxNorm normalized name: Gp160 Vaccine
DrugBank: VaxSyn (DB17827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp160 in alum over a 2‐year period in combination with placebo (n = 32)
Trial: 26202922
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC)
Trial: 7898078
Drug: Simvastatin 5
RxNorm normalized name: simvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 5 mg
Trial: 20031551
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg
Trial: 10586394
Drug: Aztreonam 1000
RxNorm normalized name: aztreonam 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aztreonam 1000 mg
Trial: 24425846
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) gel
Trial: 24673738
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei 01 supplementation (10^8 CFU, one capsule daily for 8 weeks)
Trial: 24993395
Drug: Cranberry capsules
DrugBank: Cranberry (DB10631)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry capsules (72 mg proanthocyanidins)
Trial: 27512927
Drug: Rifaximin 1200
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifaximin 1200 mg daily for 6 months
Trial: 25393287
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg zinc sulphate daily for three months
Trial: 9585822
Drug: Azelastine nasal
RxNorm normalized name: azelastine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine nasal spray
Trial: 19786940
Drug: Full-dose r-PA
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose r-PA
Trial: 15497256
Drug: Concurrent memory
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent memory task present
Trial: 24691436
Drug: Warfarin (dose-adjusted)
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin (dose-adjusted)
Trial: 1717776
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of benazepril (10 mg) and cadralazine (5 mg)
Trial: 3190990
Drug: Bupivacaine HCl
RxNorm normalized name: bupivacaine HCl
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupivacaine HCl 1.4 mg kg‐1 by i.m. injection after two oral doses of 400 mg cimetidine
Trial: 29211967
Drug: AMPH EROS
RxNorm normalized name: AMPH-b
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AMPH EROS (10-20 mg/day)
Trial: 19734131
Drug: Exercises and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercises and usual treatment (Control)
Trial: 2194055
Drug: Rokitamycin (RKM)
RxNorm normalized name: rokitamycin
DrugBank: Rokitamycin (DB13409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rokitamycin (RKM) dry syrup at approximately 30 mg/kg body weight for 5 days
Trial: 17914134
Drug: Calcium lactate
RxNorm normalized name: Calcium Lactate
DrugBank: Calcium lactate (DB13231)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium lactate (daily dose about 800 mg calcium)
Trial: 17914134
Drug: Low fat
RxNorm normalized name: Low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fat milk (daily dose about 800 mg calcium)
Trial: 2194055
Drug: Rokitamycin (RKM)
RxNorm normalized name: rokitamycin
DrugBank: Rokitamycin (DB13409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rokitamycin (RKM) dry syrup
Trial: 15770505
Drug: Intravenous anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anesthesia (TIVA)
Trial: 23735179
Drug: Vilanterol (VI)
RxNorm normalized name: Vilanterol
DrugBank: Vilanterol (DB09082)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vilanterol (VI) 25 μg
Trial: 10608202
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diltiazem (0.25 +/- 0.01 mg x kg(‐1)) and nicardipine (5.9 +/- 0.9 microg x kg(‐1) x min(‐1))
Trial: 20729233
Drug: 3-monthly 3-week
RxNorm normalized name: etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-monthly 3-week treatments with oral ciprofloxacin and inhaled colistin
Trial: 26643240
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin, 4100 U, 1/12 h for 11 d
Trial: 21042116
Drug: Avotermin 200
RxNorm normalized name: avotermin
DrugBank: Avotermin (DB11955)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avotermin 200 ng/100 μl/linear centimeter, administered once or twice
Trial: 21042116
Drug: Avotermin 50
RxNorm normalized name: avotermin
DrugBank: Avotermin (DB11955)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avotermin 50 ng/100 μl/linear centimeter, administered twice
Trial: 19214375
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day alendronate (Group A)
Trial: 2453683
Drug: Enoxacin 200
RxNorm normalized name: enoxacin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxacin 200 mg, administered orally the night before the operation, 2 to 4 hours preoperatively, and every 12 hours postoperatively for 36 hours.
Trial: 30097463
Drug: SC411 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC411 at 36 mg DHA/kg per day
Trial: 10683715
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium salt 50 mg in tablet (Cataflam)
Trial: 25580725
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with rifapentine and isoniazid
Trial: 22681407
Drug: Extended-release hydromorphone
RxNorm normalized name: hydromorphone Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release hydromorphone
Trial: 7574132
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (2 mg/kg)
Trial: 16126809
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (800 mg/day for 4 weeks)
Trial: 21613452
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with 8 g/L of a specific prebiotic mixture (short‐chain galacto‐oligosaccharides and long‐chain fructo‐oligosaccharides, ratio 9:1)
Trial: 8741209
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) 1 mg/kg or 4 mg/kg
Trial: 31278907
Drug: HFNC group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFNC group (O2 [30-60 L/minute] via HFNC)
Trial: 31227530
Drug: Vaginal prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal prostaglandin for 24 hours followed by oxytocin infusion alone
Trial: 27388828
Drug: Paclitaxel-based drug-eluting
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel-based drug-eluting balloon (DEB) angioplasty (n = 35)
Trial: 31012215
Drug: Rectal barostat
RxNorm normalized name: Sus scrofa prostate preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal barostat study (follow-up after 8-12 years)
Trial: 12200355
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 12 mg/kg/d orally from the day preceding conditioning until day 90 after transplantation
Trial: 2524362
Drug: Norethisterone enanthate
RxNorm normalized name: norethindrone enanthate
DrugBank: Norethindrone enanthate (DB14678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone enanthate 50 mg and estradiol valerate 5 mg (NET-EN/E2-V)
Trial: 10764171
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Intranasal and Intravenous PCA)
Trial: 1599072
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of pethidine added to 9 ml of 0.25% bupivacaine
Trial: 23126645
Drug: Combined simvastatin
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined simvastatin 40 mg and ezetimibe 10 mg daily
Trial: 7939440
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection therapy with papaverine/phentolamine (n = 172 evaluable)
Trial: 28077732
Drug: High-Protein breakfast
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Protein breakfast (19-20 g protein)
Trial: 28077732
Drug: High-Fiber breakfast
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Fiber breakfast (10-11 g fiber)
Trial: 17666915
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg/day
Trial: 18257182
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 50 mg Clomiphene
Trial: 25382328
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose atorvastatin 80 mg/d (HD group)
Trial: 12417278
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C administration
Trial: 18594319
Drug: TG4010 monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TG4010 monotherapy until disease progression, followed by TG4010 plus the same chemotherapy as in Arm 1
Trial: 31480423
Drug: Raw garlic
RxNorm normalized name: raw sugar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raw garlic consumption (twice or more per week)
Trial: 8775777
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen vaginal cream
Trial: 23063288
Drug: Dementia patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dementia patients prescribed warfarin
Trial: 23290819
Drug: Paclitaxel plus
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel plus cisplatin (175 mg/m(2) + 60 mg/m(2))
Trial: 24593836
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing (SRP) treatment
Trial: 31769337
Drug: Twice-daily functional
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily functional electrostimulation group (TFEG; n = 17)
Trial: 7453623
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine A/USSR/90/77
Trial: 12500513
Drug: Methylene blue
RxNorm normalized name: Methylene Blue
DrugBank: Methylene blue (DB09241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylene blue 0.5 mg.kg‐1.h‐1
Trial: 9692655
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice/day
Trial: 8356542
Drug: Rectal hydrophilic
RxNorm normalized name: PSYLLIUM HYDROPHILIC MUCILLOID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal hydrophilic gel of methohexital (25 mg/kg)
Trial: 11502785
Drug: GH administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GH administration
Trial: 24428466
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg weekly
Trial: 28806957
Drug: Artemisinin-based combination
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisinin-based combination therapy (ACT)
Trial: 18976472
Drug: Sustained-release morphine
RxNorm normalized name: morphine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release morphine
Trial: 7041728
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of vasopressin (40 U/h)
Trial: 28549161
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment Control (STC)
Trial: 15343351
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose
Trial: 25990055
Drug: Pitavastatin calcium
RxNorm normalized name: PITAVASTATIN CALCIUM
DrugBank: Pitavastatin (DB08860)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pitavastatin calcium 1 mg/d for 8 weeks
Trial: 7554521
Drug: Cyclosporine A
RxNorm normalized name: CycloSPORINE A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine A (CyA) 5 mg/kg/day and prednisolone 10 mg/day for up to 8 months
Trial: 3139705
Drug: Protein-polysaccharide vaccine
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-polysaccharide vaccine (23 volunteers)
Trial: 24164102
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid treatment
Trial: 11742886
Drug: Whole-grain meal
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain meal daily for 16 weeks
Trial: 16546738
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline at daily dose of 4 to 6 mg/kg for 16 weeks
Trial: 24287976
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) gel applied to surgical site in 6 patients.